by dmsAdmin | Apr 27, 2020
While PET MPI has seen increased interest among cardiologists, financial constraints and availability concerns have kept the modality from gaining traction in the US market. The current set of radiopharmaceuticals has built-in drawbacks, but recent innovations could...
